Free Trial
→ ❗ RSVP please! (From Behind the Markets) (Ad) Free BDRX Stock Alerts

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$3.67 +0.05 (+1.38%)
(As of 09:33 AM ET)
Compare

Recent Biodexa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
11/05/2024
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
❗ RSVP please! (Ad)

Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.

Just click here and secure your spot!
08/30/2024
3:38 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/12/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM		Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM		Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
8:34 AM		Biodexa Pharmaceuticals (Filer)
Form 424B5
07/19/2024
12:00 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K/A
07/19/2024
8:03 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/05/2024
4:24 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
7:44 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/17/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2024
8:48 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/28/2024
4:03 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
9:10 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
9:14 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
9:16 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
9:21 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
8:23 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:53 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
5:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
04/30/2024
12:11 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
8:47 PM		Biodexa Pharmaceuticals (Filer)
Form POS AM
04/29/2024
8:49 PM		Biodexa Pharmaceuticals (Filer)
Form POS AM
❗ RSVP please! (Ad)

Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.

Just click here and secure your spot!
04/29/2024
8:55 PM		Biodexa Pharmaceuticals (Filer)
Form POS AM
04/26/2024
7:45 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:19 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:24 PM		Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
03/28/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
03/18/2024
3:31 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
02/28/2024
3:14 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
02/28/2024
3:15 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BDRX) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners
JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...
Priority Gold | Sponsored
5 Stocks that could triple in a week
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
FREE investing Class TOMORROW + 2 FREE Bonuses
Over the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...
Unstoppable Prosperity | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...
Colonial Metals | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Crypto’s next big bull run?
Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...
Weiss Ratings | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored